메뉴 건너뛰기




Volumn 25, Issue 1, 2011, Pages 151-158

Current and future therapies for chronic constipation

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; ALVIMOPAN; ATI 7505; BIS (4 HYDROXYPHENYL) PYRIDYL 2 METHANE; COLCHICINE; INTESTINE CONTRACTION STIMULATING AGENT; LAXATIVE; LINACLOTIDE; LUBIPROSTONE; MACROGOL; MAGNESIUM HYDROXIDE; MU OPIATE RECEPTOR ANTAGONIST; NARONAPRIDE; NEUROTROPHIN; PRUCALOPRIDE; SEROTONIN AGONIST; TEGASEROD; UNCLASSIFIED DRUG; VELUSETRAG;

EID: 79952382110     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2011.01.005     Document Type: Article
Times cited : (48)

References (56)
  • 1
    • 67349227863 scopus 로고    scopus 로고
    • Treatment of chronic constipation: Current pharmacologic approaches and future directions
    • J. Tack, and S. Müller-Lissner Treatment of chronic constipation: current pharmacologic approaches and future directions Clin Gastroenterol Hepatol 7 5 2009 May 502 508
    • (2009) Clin Gastroenterol Hepatol , vol.7 , Issue.5 , pp. 502-508
    • Tack, J.1    Müller-Lissner, S.2
  • 5
    • 17544361897 scopus 로고    scopus 로고
    • Efficacy and safety of traditional medical therapies for chronic constipation: Systematic review
    • DOI 10.1111/j.1572-0241.2005.40925.x
    • D. Ramkumar, and S.S. Rao Efficacy and safety of traditional medical therapies for chronic constipation: systematic review Am J Gastroenterol 100 4 2005 936 971 (Pubitemid 40592390)
    • (2005) American Journal of Gastroenterology , vol.100 , Issue.4 , pp. 936-971
    • Ramkumar, D.1    Rao, S.S.C.2
  • 7
    • 33846981109 scopus 로고    scopus 로고
    • Chronic constipation: A survey of the patient perspective
    • J. Johanson, and J. Kralstein Chronic constipation: a survey of the patient perspective Aliment Pharmacol Ther 25 5 2007 599 608
    • (2007) Aliment Pharmacol Ther , vol.25 , Issue.5 , pp. 599-608
    • Johanson, J.1    Kralstein, J.2
  • 8
    • 0025109518 scopus 로고
    • Cost-effective treatment of constipation in the elderly: A randomized double-blind comparison of sorbitol and lactulose
    • DOI 10.1016/0002-9343(90)90177-F
    • F. Lederle, D. Busch, K. Mattox, M.J. West, and D.M. Aske Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose Am J Med 89 5 1990 597 601 (Pubitemid 20384316)
    • (1990) American Journal of Medicine , vol.89 , Issue.5 , pp. 597-601
    • Lederle, F.A.1    Busch, D.L.2    Mattox, K.M.3    West, M.J.4    Aske, D.M.5
  • 10
    • 0033967018 scopus 로고    scopus 로고
    • A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative
    • DOI 10.1016/S0002-9270(99)00824-2, PII S0002927099008242
    • J. Di Palma, P. DeRidder, R. Orlando, B. Kolts, and M. Cleveland A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative Am J Gastroenterol 95 2 2000 446 450 (Pubitemid 30106174)
    • (2000) American Journal of Gastroenterology , vol.95 , Issue.2 , pp. 446-450
    • Dipalma, J.A.1    Deridder, P.H.2    Orlando, R.C.3    Kolts, B.E.4    Cleveland, M.V.5
  • 11
    • 33847068622 scopus 로고    scopus 로고
    • An open-label study of chronic polyethylene glycol laxative use in chronic constipation
    • J.A. Di Palma, M.V. Cleveland, J. McGowan, and J.L. Herrera An open-label study of chronic polyethylene glycol laxative use in chronic constipation Aliment Pharmacol Ther 25 6 2007 Mar 15 703 708
    • (2007) Aliment Pharmacol Ther , vol.25 , Issue.6 , pp. 703-708
    • Di Palma, J.A.1    Cleveland, M.V.2    McGowan, J.3    Herrera, J.L.4
  • 12
    • 33745685698 scopus 로고    scopus 로고
    • Long-term efficacy and cost-effectiveness of polyethylene glycol 3350 plus electrolytes in chronic constipation: A retrospective study in a disabled population
    • DOI 10.1185/030079906X112543
    • I. Migeon-Duballet, M. Chabin, A. Gautier, T. Mistouflet, M. Bonnet, and J.M. Aubert Long-term efficacy and cost-effectiveness of polyethylene glycol 3350 plus electrolytes in chronic constipation: a retrospective study in a disabled population Curr Med Res Opin 22 6 2006 1227 1235 (Pubitemid 44000743)
    • (2006) Current Medical Research and Opinion , vol.22 , Issue.6 , pp. 1227-1235
    • Migeon-Duballet, I.1    Chabin, M.2    Gautier, A.3    Mistouflet, T.4    Bonnet, M.5    Aubert, J.M.6    Halphen, M.7
  • 13
    • 34548139322 scopus 로고    scopus 로고
    • A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation
    • DOI 10.1111/j.1572-0241.2007.01365.x
    • J. Di Palma, M. Cleveland, J. McGowan, and J. Herrera A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation Am J Gastroenterol 102 2007 1964 1971 (Pubitemid 47301532)
    • (2007) American Journal of Gastroenterology , vol.102 , Issue.9 , pp. 1964-1971
    • Di Palma, J.A.1    Cleveland, M.V.B.2    McGowan, J.3    Herrera, J.L.4
  • 14
    • 37549040228 scopus 로고    scopus 로고
    • Differences in taste between two polyethylene glycol preparations
    • M.M. Szojda, C.J. Mulder, and R.J. Felt-Bersma Differences in taste between two polyethylene glycol preparations J Gastrointestin Liver Dis 16 4 2007 379 381
    • (2007) J Gastrointestin Liver Dis , vol.16 , Issue.4 , pp. 379-381
    • Szojda, M.M.1    Mulder, C.J.2    Felt-Bersma, R.J.3
  • 17
    • 33748423741 scopus 로고    scopus 로고
    • A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence
    • DOI 10.1542/peds.2006-0220
    • V. Loening-Baucke, and D. Pashankar A randomized, prospective, comparison study of Polyethylene Glycol 3350 without electrolytes and Milk of Magnesia for children with constipation and fecal incontinence Pediatrics 118 2006 528 535 (Pubitemid 46085407)
    • (2006) Pediatrics , vol.118 , Issue.2 , pp. 528-535
    • Loening-Baucke, V.1    Pashankar, D.S.2
  • 19
    • 0027422273 scopus 로고
    • Effects of 'contact laxatives' on intestinal and colonic epithelial cell proliferation
    • K. Geboes, G. Nijs, U. Mengs, K.P. Geboes, A. Van Damme, and P. de Witte Effects of 'contact laxatives' on intestinal and colonic epithelial cell proliferation Pharmacology 47 Suppl. 1 1993 Oct 187 195 (Pubitemid 23291031)
    • (1993) Pharmacology , vol.47 , Issue.SUPPL. 1 , pp. 187-195
    • Geboes, K.1    Nijs, G.2    Mengs, U.3    Geboes, K.P.J.4    Van Damme, A.5    De Witte, P.6
  • 20
    • 77950519743 scopus 로고    scopus 로고
    • Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation
    • S. Mueller-Lissner, M.A. Kamm, A. Wald, U. Hinkel, U. Koehler, and E. Richter Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation Am J Gastroenterol 105 4 2010 Apr 897 903
    • (2010) Am J Gastroenterol , vol.105 , Issue.4 , pp. 897-903
    • Mueller-Lissner, S.1    Kamm, M.A.2    Wald, A.3    Hinkel, U.4    Koehler, U.5    Richter, E.6
  • 22
    • 33846347644 scopus 로고    scopus 로고
    • The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
    • DOI 10.1053/j.gastro.2006.11.002, PII S001650850602436X
    • M.D. Gershon, and J. Tack The serotonin signaling system: from basic understanding to drug development for functional GI disorders Gastroenterology 132 1 2007 Jan 397 414 (Pubitemid 46127672)
    • (2007) Gastroenterology , vol.132 , Issue.1 , pp. 397-414
    • Gershon, M.D.1    Tack, J.2
  • 24
    • 0033258353 scopus 로고    scopus 로고
    • Cardiac adverse effects of gastrointestinal prokinetics
    • DOI 10.1046/j.1365-2036.1999.00655.x
    • M. Tonini, F. de Ponti, A. di Nucci, and F. Crema Review article: cardiac adverse effects of gastrointestinal prokinetics Aliment Pharmacol Ther 13 1999 1585 1591 (Pubitemid 30009075)
    • (1999) Alimentary Pharmacology and Therapeutics , vol.13 , Issue.12 , pp. 1585-1591
    • Tonini, M.1    De Ponti, F.2    Di Nucci, A.3    Crema, F.4
  • 25
    • 77958452881 scopus 로고    scopus 로고
    • Safety and efficacy of tegaserod therapy in patients with irritable bowel syndrome or chronic constipation
    • B. Al-Judaibi, N. Chande, and J. Gregor Safety and efficacy of tegaserod therapy in patients with irritable bowel syndrome or chronic constipation Can J Clin Pharmacol 17 1 2010 Winter e194 e200
    • (2010) Can J Clin Pharmacol , vol.17 , Issue.1
    • Al-Judaibi, B.1    Chande, N.2    Gregor, J.3
  • 27
    • 0033005188 scopus 로고    scopus 로고
    • 4 agonist, prucalopride, in healthy humans
    • E.P. Bouras, M. Camilleri, D.D. Burton, and S. McKinzie Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans Gut 44 5 1999 682 686 (Pubitemid 29195916)
    • (1999) Gut , vol.44 , Issue.5 , pp. 682-686
    • Bouras, E.P.1    Camilleri, M.2    Burton, D.D.3    McKinzie, S.4
  • 28
    • 0035121508 scopus 로고    scopus 로고
    • Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder
    • E.P. Bouras, M. Camilleri, D.D. Burton, G. Thomforde, S. McKinzie, and A.R. Zinsmeister Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder Gastroenterology 120 2 2001 354 360 (Pubitemid 32147632)
    • (2001) Gastroenterology , vol.120 , Issue.2 , pp. 354-360
    • Bouras, E.P.1    Camilleri, M.2    Burton, D.D.3    Thomforde, G.4    McKinzie, S.5    Zinsmeister, A.R.6
  • 29
    • 44349130441 scopus 로고    scopus 로고
    • A placebo-controlled trial of prucalopride for severe chronic constipation
    • DOI 10.1056/NEJMoa0800670
    • M. Camilleri, R. Kerstens, A. Rykx, and L. Vandeplassche A placebo-controlled trial of prucalopride for severe chronic constipation N Engl J Med 358 2008 2344 2354 (Pubitemid 351749158)
    • (2008) New England Journal of Medicine , vol.358 , Issue.22 , pp. 2344-2354
    • Camilleri, M.1    Kerstens, R.2    Rykx, A.3    Vandeplassche, L.4
  • 30
    • 58149084950 scopus 로고    scopus 로고
    • Clinical trial: The efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation-a 12-week, randomized, double-blind, placebo-controlled study
    • E.M. Quigley, L. Vandeplassche, R. Kerstens, and J. Ausma Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation-a 12-week, randomized, double-blind, placebo-controlled study Aliment Pharmacol Ther 29 2009 315 328
    • (2009) Aliment Pharmacol Ther , vol.29 , pp. 315-328
    • Quigley, E.M.1    Vandeplassche, L.2    Kerstens, R.3    Ausma, J.4
  • 31
    • 61649119045 scopus 로고    scopus 로고
    • Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives
    • J. Tack, M. van Outryve, G. Beyens, R. Kerstens, and L. Vandeplassche Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives Gut 58 2009 357 365
    • (2009) Gut , vol.58 , pp. 357-365
    • Tack, J.1    Van Outryve, M.2    Beyens, G.3    Kerstens, R.4    Vandeplassche, L.5
  • 32
    • 72049090263 scopus 로고    scopus 로고
    • Safety assessment of prucalopride in elderly patients with constipation: A double-blind, placebo-controlled study
    • M. Camilleri, G. Beyens, R. Kerstens, P. Robinson, and L. Vandeplassche Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study Neurogastroenterol Motil 21 12 2009 Dec p. 1256-e117
    • (2009) Neurogastroenterol Motil , vol.21 , Issue.12
    • Camilleri, M.1    Beyens, G.2    Kerstens, R.3    Robinson, P.4    Vandeplassche, L.5
  • 33
    • 77955493094 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation
    • S. Müller-Lissner, A. Rykx, R. Kerstens, and L. Vandeplassche A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation Neurogastroenterol Motil 22 9 2010 Sep 991 998 e255
    • (2010) Neurogastroenterol Motil , vol.22 , Issue.9 , pp. 991-998
    • Müller-Lissner, S.1    Rykx, A.2    Kerstens, R.3    Vandeplassche, L.4
  • 34
    • 72449143707 scopus 로고    scopus 로고
    • Effects of velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation
    • M.L. Manini, M. Camilleri, M. Goldberg, S. Sweetser, S. McKinzie, and D. Burton Effects of velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation Neurogastroenterol Motil 22 1 2010 Jan 42 49 e7-e8
    • (2010) Neurogastroenterol Motil , vol.22 , Issue.1 , pp. 42-49
    • Manini, M.L.1    Camilleri, M.2    Goldberg, M.3    Sweetser, S.4    McKinzie, S.5    Burton, D.6
  • 35
    • 78649489728 scopus 로고    scopus 로고
    • Clinical trial: The efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - A 4-week, randomized, double-blind, placebo-controlled, dose-response study
    • M. Goldberg, Y.P. Li, J.F. Johanson, A.W. Mangel, M. Kitt, and D.T. Beattie Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study Aliment Pharmacol Ther 32 9 2010 Nov 1102 1112
    • (2010) Aliment Pharmacol Ther , vol.32 , Issue.9 , pp. 1102-1112
    • Goldberg, M.1    Li, Y.P.2    Johanson, J.F.3    Mangel, A.W.4    Kitt, M.5    Beattie, D.T.6
  • 37
    • 34147173976 scopus 로고    scopus 로고
    • Lubiprostone: A chloride channel activator
    • DOI 10.1097/01.mcg.0000225665.68920.df, PII 0000483620070400000003
    • B.E. Lacy, and L.C. Levy Lubiprostone: a chloride channel activator J Clin Gastroenterol 41 4 2007 Apr 345 351 (Pubitemid 46573059)
    • (2007) Journal of Clinical Gastroenterology , vol.41 , Issue.4 , pp. 345-351
    • Lacy, B.E.1    Campbell Levy, L.2
  • 38
    • 33645837674 scopus 로고    scopus 로고
    • Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers
    • M. Camilleri, A.E. Bharucha, R. Ueno, D. Burton, G.M. Thomforde, and K. Baxter Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers Am J Physiol Gastrointest Liver Physiol 290 5 2006 May G942 G947
    • (2006) Am J Physiol Gastrointest Liver Physiol , vol.290 , Issue.5
    • Camilleri, M.1    Bharucha, A.E.2    Ueno, R.3    Burton, D.4    Thomforde, G.M.5    Baxter, K.6
  • 39
    • 37849024665 scopus 로고    scopus 로고
    • Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation
    • J.F. Johanson, D. Morton, J. Geenen, and R. Ueno Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation Am J Gastroenterol 103 1 2008 Jan 170 177
    • (2008) Am J Gastroenterol , vol.103 , Issue.1 , pp. 170-177
    • Johanson, J.F.1    Morton, D.2    Geenen, J.3    Ueno, R.4
  • 40
    • 77950347294 scopus 로고    scopus 로고
    • Efficacy and safety of lubiprostone in patients with chronic constipation
    • C.F. Barish, D. Drossman, J.F. Johanson, and R. Ueno Efficacy and safety of lubiprostone in patients with chronic constipation Dig Dis Sci 55 4 2010 Apr 1090 1097
    • (2010) Dig Dis Sci , vol.55 , Issue.4 , pp. 1090-1097
    • Barish, C.F.1    Drossman, D.2    Johanson, J.F.3    Ueno, R.4
  • 41
    • 58149103805 scopus 로고    scopus 로고
    • Clinical trial: Lubiprostone in patients with constipation-associated irritable bowel syndrome - Results of two randomized, placebo-controlled studies
    • D.A. Drossman, W.D. Chey, J.F. Johanson, R. Fass, C. Scott, and R. Panas Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies Aliment Pharmacol Ther 29 3 2009 Feb 1 329 341
    • (2009) Aliment Pharmacol Ther , vol.29 , Issue.3 , pp. 329-341
    • Drossman, D.A.1    Chey, W.D.2    Johanson, J.F.3    Fass, R.4    Scott, C.5    Panas, R.6
  • 42
    • 77249162216 scopus 로고    scopus 로고
    • Taking a lesson from microbial diarrheagenesis in the management of chronic constipation
    • A.E. Bharucha, and S.A. Waldman Taking a lesson from microbial diarrheagenesis in the management of chronic constipation Gastroenterology 138 3 2010 Mar 813 817
    • (2010) Gastroenterology , vol.138 , Issue.3 , pp. 813-817
    • Bharucha, A.E.1    Waldman, S.A.2
  • 45
    • 77957895684 scopus 로고    scopus 로고
    • Efficacy and safety of once daily linaclotide administered orally for 12-Weeks in patients with chronic constipation: Results from 2 randomized, double-blind, placebo-controlled phase 3 trials
    • A. Lembo, H. Schneier, B.J. Lavins, S.J. Shiff, J.E. MacDougall, and X.D. Jia Efficacy and safety of once daily linaclotide administered orally for 12-Weeks in patients with chronic constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials Gastroenterology 139 2010 S53 S54 [abstract]
    • (2010) Gastroenterology , vol.139
    • Lembo, A.1    Schneier, H.2    Lavins, B.J.3    Shiff, S.J.4    MacDougall, J.E.5    Jia, X.D.6
  • 46
    • 50249107478 scopus 로고    scopus 로고
    • Efficacy and safety of mu-opioid antagonists in the treatment of opioid-induced bowel dysfunction: Systematic review and meta-analysis of randomized controlled trials
    • E. McNicol, D.B. Boyce, R. Schumann, and D. Carr Efficacy and safety of mu-opioid antagonists in the treatment of opioid-induced bowel dysfunction: systematic review and meta-analysis of randomized controlled trials Pain Med 9 6 2008 Sep 634 659
    • (2008) Pain Med , vol.9 , Issue.6 , pp. 634-659
    • McNicol, E.1    Boyce, D.B.2    Schumann, R.3    Carr, D.4
  • 47
    • 42649091132 scopus 로고    scopus 로고
    • Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness: A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study
    • DOI 10.1016/j.jpainsymman.2007.12.005, PII S0885392408000936
    • R.K. Portenoy, J. Thomas, M.L. Moeh Boatwright, D. Tran, F.L. Galasso, and N. Stambler Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study J Pain Symptom Manage 35 5 2008 May 458 468 (Pubitemid 351601995)
    • (2008) Journal of Pain and Symptom Management , vol.35 , Issue.5 , pp. 458-468
    • Portenoy, R.K.1    Thomas, J.2    Moehl Boatwright, M.L.3    Tran, D.4    Galasso, F.L.5    Stambler, N.6    Von Gunten, C.F.7    Israel, R.J.8
  • 50
    • 45549109284 scopus 로고    scopus 로고
    • Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain
    • L. Webster, J.P. Jansen, J. Peppin, B. Lasko, G. Irving, and B. Morlion Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain Pain 137 2 2008 Jul 15 428 440
    • (2008) Pain , vol.137 , Issue.2 , pp. 428-440
    • Webster, L.1    Jansen, J.P.2    Peppin, J.3    Lasko, B.4    Irving, G.5    Morlion, B.6
  • 51
    • 20144366569 scopus 로고    scopus 로고
    • Alvimopan: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction - A 21-day treatment-randomized clinical trial
    • DOI 10.1016/j.jpain.2004.12.001
    • D.M. Paulson, D.T. Kennedy, R.A. Donovick, R.L. Carpenter, M. Cherubini, and L. Techner Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction - a 21-day treatment-randomized clinical trial J Pain 6 3 2005 Mar 184 192 (Pubitemid 40365022)
    • (2005) Journal of Pain , vol.6 , Issue.3 , pp. 184-192
    • Paulson, D.M.1    Kennedy, D.T.2    Donovick, R.A.3    Carpenter, R.L.4    Cherubini, M.5    Techner, L.6    Du, W.7    Ma, Y.8    Schmidt, W.K.9    Wallin, B.10    Jackson, D.11
  • 53
    • 77956408794 scopus 로고    scopus 로고
    • The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health
    • B.S. Wong, A.S. Rao, M. Camilleri, N. Manabe, S. McKinzie, and I. Busciglio The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health Aliment Pharmacol Ther 32 7 2010 Oct 884 893
    • (2010) Aliment Pharmacol Ther , vol.32 , Issue.7 , pp. 884-893
    • Wong, B.S.1    Rao, A.S.2    Camilleri, M.3    Manabe, N.4    McKinzie, S.5    Busciglio, I.6
  • 56
    • 77649235471 scopus 로고    scopus 로고
    • Colchicine is effective for short-term treatment of slow transit constipation: A double-blind placebo-controlled clinical trial
    • S.A. Taghavi, S. Shabani, A. Mehramiri, A. Eshraghian, S.M. Kazemi, and M. Moeini Colchicine is effective for short-term treatment of slow transit constipation: a double-blind placebo-controlled clinical trial Int J Colorectal Dis 25 3 2010 Mar 389 394
    • (2010) Int J Colorectal Dis , vol.25 , Issue.3 , pp. 389-394
    • Taghavi, S.A.1    Shabani, S.2    Mehramiri, A.3    Eshraghian, A.4    Kazemi, S.M.5    Moeini, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.